Table I.
Correlations between miR-29c-3p and clinicopathological features of HCC patients (n=60).
| miR-29c-3p expression | ||||
|---|---|---|---|---|
| Variables | No. of cases | Low (n=39) | High (n=21) | P-value |
| Age (years) | 0.515 | |||
| <50 | 28 | 17 | 11 | |
| ≥50 | 32 | 22 | 10 | |
| Sex | 0.548 | |||
| Male | 34 | 21 | 13 | |
| Female | 26 | 18 | 8 | |
| Tumor size (cm) | 0.013 | |||
| ≤5 | 27 | 13 | 14 | |
| >5 | 33 | 26 | 7 | |
| AFP (ng/ml) | 0.399 | |||
| ≤20 | 27 | 16 | 11 | |
| >20 | 33 | 23 | 10 | |
| TNM stage | 0.003 | |||
| I/II | 27 | 12 | 15 | |
| III/IV | 33 | 27 | 6 | |
| Liver cirrhosis | 0.664 | |||
| Presence | 32 | 20 | 12 | |
| Absence | 28 | 19 | 9 | |
| HBsAg | 0.254 | |||
| Positive | 37 | 22 | 15 | |
| Negative | 23 | 17 | 6 | |
| Vascular invasion | 0.183 | |||
| Presence | 27 | 20 | 7 | |
| Absence | 33 | 19 | 14 | |
| Multiplicity | 0.047 | |||
| Single | 24 | 12 | 12 | |
| Multiple (≥2) | 36 | 27 | 9 | |
| Intrahepatic metastasis | 0.217 | |||
| Presence | 25 | 14 | 11 | |
| Absence | 35 | 25 | 10 | |
HCC, hepatocellular carcinoma.